The latest price target for Agilon Health (NYSE:AGL) was reported by Macquarie on December 16, 2024. The analyst firm set a price target for $3.00 expecting AGL to rise to within 12 months (a possible 57.89% upside). 32 analyst firms have reported ratings in the last year.

The latest analyst rating for Agilon Health (NYSE:AGL) was provided by Macquarie, and Agilon Health initiated their neutral rating.

There is no last upgrade for Agilon Health

The last downgrade for Agilon Health Inc happened on November 11, 2024 when JMP Securities changed their price target from N/A to N/A for Agilon Health Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on December 16, 2024 so you should expect the next rating to be made available sometime around December 16, 2025.

While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a initiated with a price target of $0.00 to $3.00. The current price Agilon Health (AGL) is trading at is $1.90, which is within the analyst’s predicted range.